ArticleCancers2025

Prospective, Randomized, Comparative Study of Myeloablative Fludarabine/Busulfan and Fludarabine/Busulfan/Total Body Irradiation Conditioning in Myeloid Diseases.

Hyung C Suh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.